| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.9M | — | +82.6% |
| Cost of Revenue | $1.9M | — | +53.4% |
| Gross Profit | $2.0M | — | +124.1% |
| R&D Expense | $3.8M | — | -23.7% |
| SG&A Expense | $4.1M | — | -1.9% |
| Operating Income | -$8.6M | — | +21.5% |
| Pre-tax Income | -$8.6M | — | +8.4% |
| Income Tax | $0 | — | — |
| Net Income | -$8.6M | — | +8.4% |
| EPS (Basic) | -$0.09 | — | +25.0% |
| EPS (Diluted) | -$0.09 | — | +25.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $40.8M | +16.2% | +23.2% |
| Accounts Receivable | $3.8M | -27.8% | -28.9% |
| Inventory | $6.3M | -10.8% | +36.4% |
| Current Assets | $56.0M | +10.1% | +15.8% |
| Total Assets | $60.3M | +9.2% | +13.0% |
| Current Liabilities | $10.2M | -13.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.0M | — | +2.6% |
| Capital Expenditures | $242K | — | -48.7% |
| Investing Cash Flow | -$242K | — | +48.7% |
| Financing Cash Flow | $14.5M | — | +159.5% |
| Free Cash Flow | -$9.3M | — | +4.8% |
| +27.3% |
| Long-term Debt | $13.1M | — | — |
| Total Liabilities | $26.0M | +82.2% | +153.1% |
| Stockholders' Equity | $34.4M | -16.2% | -20.3% |